biomea fusion
Jeremy Pettus is an Associate Professor of Medicine in the Division of Endocrinology at the University of California, San Diego. After being diagnosed with type 1 diabetes himself at the age of 15, Dr. Pettus has dedicated his career to treating and educating others with the disease. He now specializes in type 1 diabetes clinical and translational research with studies utilizing metabolic techniques such as glycemic clamps to quantify insulin resistance. He also has experience in immunotherapeutics for recently diagnosed patients, islet cell encapsulation/transplantation, and technology-based approaches such as the artificial pancreas and continuous glucose monitoring. In addition to his clinical research at UCSD, Dr. Pettus has interest in patient empowerment through education and works with the not-for-profit organization Taking Control of Your Diabetes. With this organization, Dr. Pettus produces educational content for patients living with diabetes.
This person is not in the org chart
This person is not in any offices
biomea fusion
Biomea Fusion, Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of irreversible small molecules to treat patients with genetically defined cancers. The company was formed in 2017 by a small group of biotech executives that came together with the common goal of achieving better therapies for patients.